<span id="62xs7"><blockquote id="62xs7"></blockquote></span>
<span id="62xs7"><blockquote id="62xs7"><b id="62xs7"></b></blockquote></span>
<sub id="62xs7"></sub>
<sub id="62xs7"></sub>
<track id="62xs7"><em id="62xs7"></em></track>
<track id="62xs7"><em id="62xs7"></em></track>
Jump to navigation
Login
Enter your keywords
Main menu
Products
About
Partners
Get Help
Resources
Contact
Our Publications
Posters
Impact of Inactive FVIII Antigen in FVIII Deficient Plasma on the Measurement of FVIII Inhibitors
Comparison of a Chromogenic vs APPT-based FVIII Activity Assay in the Recovery of a Pegylated FVIII Replacement Therapy in Plasma Samples
Validation of a New Kit for the Quantitative Determination of Chromogenic FIX Activity
Laboratory Validation of
CRYO
check
? Chromogenic Factor VIII Across Multiple Coagulation Analyzers
Comparison of Hexagonal Phase Phospholipid Neutralization Assays for Lupus Anticoagulant Detection
Performance of
CRYO
check
? Chromogenic Factor VIII in the Recovery of Factor VIII Replacement Therapies
CRYO
check
? Chromogenic Factor VIII: A New Kit for the Determination of FVIII:C Activity
Laboratory Validation of a Novel Hexagonal Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Detection
Effects of Anticoagulants and Common Interfering Substances on Four Commercially Available dRVVT Assays
Effects of Common Interferents in Hexagonal Phase Phospholipid Neutralization Testing
A Standardized Kit for a Chromogenic Modified Nijmegen-Bethesda Assay: Repeatability, Reproducibility, and Analytical Sensitivity
Emicizumab Impact on Factor VIII Inhibitor Determination in Plasma Samples from Persons with Hemophilia A (PwHA) Using a New Kit for Modified Nijmegen-Bethesda Assay (MNBA)
Agreement Between a Chromogenic Modified Nijmegen-Bethesda Assay and a Qualitative ELISA test in Detection of Factor VIII Inhibitors in Plasma from Persons with Hemophilia A (PwHA)
Performance of a New Kit for a Modified Nijmegen-Bethesda Assay: Comparison of a Chromogenic Versus a Clot-based Factor VIII Inhibitor Assay in Plasma from Persons with Hemophilia A
Assessment of clotting activity of recombinant FIX Fc fusion protein in European HTCs (Poster available to healthcare professionals only; login required)
Recombinant Factor IX Fc Fusion Protein (rFIXFc) Clotting Activity Assessment in International Hemophilia Treatment Centers
Assessment of clotting activity of recombinant factor IX Fc fusion protein (rFIXFc) in plasma samples at haemophilia treatment centres in Australia and New Zealand
Assessment of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Clotting Activity in Plasma Samples at Canadian Hemophilia Treatment Centres
PF4-R, a Novel Heparin Neutralizing Reagent Suitable for Automated Coagulometers: Comparison with Heparinase in Routine Coagulation Tests
I have hemophilia and I am okay! Infographic
Journal
Sommer JM, Sadeghi-Khomami A, Barnowski C, Wikén M, Willemze AJ. Real-world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples. Int J Lab Hematol. 2020;42:350–358.
Back to Top
91精品国产91久久久久久不卡,国产精品久久久久久搜索,精品国产福利久久久,106久久综合狠狠综合久久
